# Chaosheng Capital

> Chaosheng Capital is a VC fund backing Biotechnology, Software and Biopharma. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 11
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Chaosheng Capital is a VC fund focused on Biotechnology and Software. Chaosheng Capital is operates venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 36% |
| Software | 2 | 18% |
| Biopharma | 2 | 18% |
| Health Care | 2 | 18% |
| Manufacturing | 2 | 18% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 45% |
| Series A | 4 | 36% |
| Angel | 2 | 18% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 8 | 73% |
| Singapore | 1 | 9% |
| United States | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SynMetaBio | SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather. | $14.7M | Series A | Jul 06, 2026 |  |
| Maibozhixing | MaiboZhixing is an innovative company focused on antibody drug development and dedicated to developing next-generation antibody therapies for the treatment of inflammatory and autoimmune diseases. | $14.5M | Angel | Mar 23, 2026 |  |
| Noah AI | Noah AI is a research platform that generates reports quickly, reducing the time spent on research tasks. It integrates with tools like Google Drive and Notion, allowing users to work across documents, spreadsheets, and presentations. The platform provides access to a database of investment research reports and drug pipeline entries. This supportsusers in making informed decisions in the healthcare sector. |  | Seed | Feb 17, 2025 |  |
| DeepVerse | DeepVerse "magic technology" takes materials informatics as the background, combines artificial intelligence, computational physics, high-throughput experiments, and other cutting-edge technologies, integrates cross-field data, conducts forward prediction and reverse design, and accelerates the industrial implementation of new materialresearch and development technologies, aiming to provide the industry with "problem-oriented" breakthrough solutions. |  | Seed | Mar 14, 2023 |  |
| Maize Yufeng | Maize Yufeng is a research and development company that creates data-based and molecular design breeding systems for enhanced corn breeding. | $4.2M | Seed | Mar 06, 2023 |  |
| Fabarta | Fabarta delivers solutions for sophisticated mining business values in a vast number of diverse data environments using graph intelligence, as well as establishing an AI-oriented Infra. |  | Angel | Jan 01, 2022 |  |
| Fabarta | Fabarta delivers solutions for sophisticated mining business values in a vast number of diverse data environments using graph intelligence, as well as establishing an AI-oriented Infra. |  | Seed | Jan 01, 2022 |  |
| Protoga | Yuan Yu Bio is a biotech firm that focused on the development of innovative microalgae biosynthesis technology. | $1.6M | Seed | Dec 21, 2021 |  |
| Dynasty Gene | Developer of synthetic biology technology and provider of biotechnology consulting services. The company focuses on technology development, technology consulting, technology transfer, and technical services in the biotechnology field, enabling their clients to make advancement in the field of next-generation DNA sequencing (NGS). The company hasits own independent intellectual property rights on their Micropore high-throughput DNA synthesis platform, allowing the company to launch a series of products including: liquid biopsy solutions, NGS library capture kits, etc. | $15.6M | Series A | Jun 05, 2021 |  |
| JOINN Biologics | JOINN Biologics is a California Bay Area-based company that is committed to the advancement of biotech and biopharmaceutics through our premier contract manufacturing and development services for biologics and advanced therapies. A vital part of the JOINN Family's successful 20+ year track record of supporting drug discovery and development,we provide a complete range of CDMO services, from early development to clinical manufacturing, for our clients and partners on a global scale.Core Capabilities • Molecular/developability assessment• cGMP clinical trial materials production• Commercial-scale cGMP manufacturing• Non-GMP protein expression and purification• Cell line development• Upstream process development• Downstream purification development• Analytical and formulation development• Documentation and reporting to support regulatory filingsMissionIt is our mission to provide our global clients and partners with a complete range of premier contract development and manufacturing services for biologics and advanced therapies, from early custom development to clinical manufacturing, to further accelerate the development of high-quality biologics, meeting patients' needs and delivering long-lasting value to the biotech and biopharmaceutical industry. | $60M | Series A | Dec 10, 2019 |  |

10 of 11 investments shown.

## Co-investors
- [Jiangmen Venture Capital](https://shizune.co/investors/profile/jiangmen-venture-capital) — VC Fund, 2 deals together
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund, 2 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [BRV](https://shizune.co/investors/profile/blue-run-ventures-china) — VC Fund, 1 deal together
- [CITIC Agriculture](https://shizune.co/investors/profile/citic-agriculture) — VC Fund, 1 deal together
- [Everbright](https://shizune.co/investors/profile/everbright) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in Singapore](https://shizune.co/investors/manufacturing-investors-singapore)
- [Manufacturing VC Funds in Singapore](https://shizune.co/investors/manufacturing-vc-funds-singapore)

## FAQ

### What does Chaosheng Capital invest in?

Chaosheng Capital invests primarily in Biotechnology, Software and Biopharma startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chaosheng Capital last invest?

The most recent investment recorded for Chaosheng Capital closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co